![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Hanzhong City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Oxfendazole For Veterinary Use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-123 - Rev 04
This Chemical Type CEP, issued on December 19, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1458 associated with this CEP further emphasizes